Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine

Infection and Immunity

Volumn 64, Issue 10, 1996, Pages 4078-4084

  Zepp, F ^a   Knuf, M ^a   Habermehl, P ^a   Schmitt, H J ^b   Rebsch, C ^a   Schmidtke, P ^a   Clemens, R ^c   Slaoui, M ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CELLULAR IMMUNITY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INFANT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION;

EID: 0029794016     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.10.4078-4084.1996     Document Type: Article

References (54)

1. Adamson, P. C., T. C. Wu, B. D. Meade, M. Rubin, C. R. Manclark, and P. A. Pizzo. 1989. Pertussis in a previously immunized child with human immunodeficiency virus infection. J. Pediatr. 115:589-592.
2. Ad Hoc Group for the Study of Pertussis Vaccines. 1988. Placebo-controlled trial of two accllular pertussis vaccines in Sweden-protective efficacy and adverse events. Lancet i:955-960.
3. Anderson, E. L., R. B. Belshe, and J. Bartram. 1988. Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. J. Infect. Dis. 157:731-737.
4. Arciniega, J. L., R. D. Shahin, W. N. Burnette, T. D. Bartley, D. W. Whiteley, V. L. Mar, and D. L. Burns. 1991. Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin. Infect. Immun. 59:3407-3410.
5. Baraff, L. J., C. L. Cody, and J. D. Cherry. 1984. DTP associated reactions: an analysis by injection site, manufacturer, prior reactions and dose. Pediatrics 73:31-36.
6. + T lymphocytes. Immunol. Today 9:268-274.
7. Bromberg, K., G. Tannis, and P. Steiner. 1991. Detection of Bordetella pertussis associated with the alveolar macrophages of children with immunodeficiency virus infection. Infect. Immun. 59:4715-4719.
8. Burstyn, D. G., L. J. Baraff, M. S. Peppler, R. D. Leake, J. St. Geme, Jr., and C. R. Mandark. 1983. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect. Immun. 41:1150-1156.
9. Cahill, E. S., D. T. O'Hagan, L. Illum, A. Barnard, K. H. G. Mills, and K. Redhead. 1995. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. Vaccine 13:455-162.
10. Charles, I. G., J. Li, M. Roberts, K. Beesley, M. Romanos, D. J. Pickard, M. Francis, D. Campell, G. Dougan, M. J. Brennan, C. R. Manclark, M. A. Jenesen, I. Heron, A. Chubb, P. Novotny, and N. F. Fairweather. 1991. Identification and characterization of a protective immuno-dominant B-cell epitope of pertactin (P.69) from Bordetella pertussis. Eur. J. Immunol. 21:1147-1153.
11. Chong, P., G. Zobrist, C. H. Sia, S. Loosmore, and M. Klein. 1992. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides. Infect. Immun. 60:4640-4647.
12. De Magistris, M. T., R. Rappuoli, and A. Tagliabue. 1991. Human T cell immunity against Bordetella pertussis analysed at clonal level. Ann. 1st. Super. Sanita 27:33-36.
13. De Magistris, M. T., M. Romano, A. Bartoloni, R. Rappuoli, and A. Tagliabue. 1989. Human T cell clones define SI subunit as the most immunodominant moiety of pertussis toxin and determine its epitope map. J. Exp. Med. 169:1519-1532.
14. De Magistris, M. T., M. Romano, S. Nuti, R. Rappuoli, and A. Tagliabue. 1988. Dissecting human T cell responses against Bordetella species. J. Exp. Med. 168:1351-1362.
15. Edwards, K. M., and M. D. Decker. 1996. Acellular pertussis vaccines for infants. N. Engl. J. Med. 334:391-392.
16. Ewanowich, C. A., A. R, Melton, A. A. Weiss, R. K. Sherburne, and M. S. Peppler. 1989. Invasion of HeLa 299 cells by virulent Bordetella pertussis. Infect. Immun. 57:2698-2704.
17. Gearing, A. J. H., C. R. Bird, K. Redhead, and M. Thomas. 1989. Human cellular immune responses to Bordetella pertussis infection. FEMS Microbiol. Immunol. 47:205-212.
18. Gray, D. 1993. Immunological memory. Annu. Rev. Immunol. 11:49-77.
19. Greco, D., S. Salmaso, P. Mastrantonio, M. Giullano, A. Tozzi, A. Anemona, M. L. Ciofo Degli Atli, A. Giamraanco, P. Panel, W. C. Blackwelder, D. L. Klein, S. G. F. Wassilak, and the Progetto Pertosse Working Group. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
20. Grob, P. R., M. J. Crowder, and J. F. Robbins. 1981. Effect of vaccination on severity and dissemination of whooping cough. Br. Med. J. 282:1925-1928.
21. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
22. + T cells from CD45RA to CD45RO is accompanied by cell activation and proliferation. Cytometry 19:343-352.
23. Jones, D. H., B. W. McBride, H. Jeffery, D. T. O'Hagan, A. Robinson, and G. H. Farrar. 1995. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine 13:675-681.
24. Kaufmann, S. H. E. 1995. Immunity to intracellular microbial pathogens. Immunol. Today 16:338-342.
25. Kimura, A., K. T. Mountzouros, D. A. Relman, S. Falkow, and J. L. Cowell. 1990. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infecl. Immun. 58:7-16.
26. Lee, C. K., A. L. Roberts, T. M. Finn, and J. J. Mekalanos. 1990. Invasion of HeLa 229, Chinese hamster ovary, and U937 cells by Bordetella pertussis, p. 3-18. In C. R. Manclark (ed.), Proceedings of the Sixth International Symposium on Pertussis. U.S. Public Health Service, Bethesda, Md.
27. Linnemann, C. C., Jr. 1978. Host-parasite interactions in pertussis, p. 3-18. In C. R. Manclark and J. C. Hill (ed.), International Symposium on Pertussis. U.S. Public Health Service, Bethesda, Md.
28. Mills, K. H. G. 1989. Recognition of foreign antigen by T cells and their role in immune protection. Curr. Opin. Infect. Dis. 2:804-813.
29. Mills, K. H. G., A. Barnard, J. Walkins, and K. Redhead. 1990. Specificity of the T-cell response to Bordetella pertussis in aerosol-infected mice, p. 166-174. In C. R. Manclark (ed.), Proceedings of the Sixth International Symposium on Pertussis. Publication no. PDA 90-1164. U.S. Public Health Service, Bethesda, Md.
30. Mills, K. H. G., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Thl cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
31. Morse, J. H., A. S. Kong, J. Linderbaum, and S. I. Morse. 1977. The mitogenic effects of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes. J. Clin. Invest. 60:683-692.
32. Mosmann, T. R., and R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and function of helper T cells. Adv. Immunol. 46:111-147.
33. Navotny, P., M. E. Macaulay, T. C. Hart, and F. Skvaril. 1990. Analysis of antibody profiles in children with whooping cough. Dev. Biol. Stand. 73:267-273.
34. Olander, R.-M., A. Mutotiala, M. Karvonen, T. Kuronen, and K. Runeberg- Nymen. 1990. Serum antibody responses to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model. Microb. Pathog. 8:37-45.
35. + T-cell clones against Bordetella pertussis. Infect. Immun. 59:3768-3773.
36. Petersen, J. W., P. Andersen, P. H. Ibsen, C. Capiau, C. H. Wachmann, K. Haslov, and I. Heron. 1993. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine 11:463-472.
37. Petersen, J. W., A. Holm, P. H. Ibsen, K. Haslov, and I. Heron. 1993. Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin. Infect. Immun. 61:56-63.
38. Petersen, J, W., P. H. Ibsen, M. W. Bentzon, C. Capiau, and I. Heron. 1991. The cell-mediated and humoral immune response to vaccination with acellular and whole-cell pertussis vaccine in adult humans. FEMS Microbiol. Immunol. 3(5):279-287.
39. Petersen, J. W., P. H. Ibsen, K. Haslov, and I. Heron. 1992. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleens of mice aerosol infected with Bordetella pertussis. Infect Immun. 60:4563-4570.
40. Podda, A., L. Nencioni, M. T. De Magistris, A. Di Tommaso, P. Bossu, S. Nuti, P. Pileri, S. Peppoloni, M. Bugnoli, P. Ruggiero, I. Marsili, A. D'Errico, A. Tagliabue, and R. Rappuoli. 1990. Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J. Exp. Med. 172:861-868.
41. Pollock, T. M., J. Y. Mortimer, E. Miller, and G. Smith. 1984. Symptoms after primary immunization with DTP and DT vaccine. Lancet ii:146-149.
42. Redhead, K., J. Watkins, A. Barnard, and K. H. G. Mills. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:3199-3198.
43. Robinson, A., L. I. Irons, and L. A. E. Ashworth. 1985. Pertussis vaccine: present status and future prospects. Vaccine 3:11-22.
44. Romagnani, S. 1991. Human Thl andTh2 subsets: doubt no more. Immunol. Today 12:256-257.
45. Ruuskanen, O., A. Noel, A. Putto-Laurila, J. Petre, C. Capiau, A. Delem, D. Vandevoorde, E. Simoen, D. E. Teuwen, H. Bogaerts, and F. E. Andre. 1991. Development of an acellular pertussis vaccine and its administration as a booster in healthy adults. Vaccine 9:117-121.
46. Sato, Y., and H. Sato. 1985. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these liters with sera of pertussis convalescent children. Dev. Biol. Stand. 61:367-372.
47. Sato, Y., and H. Sato. 1988. Animal models of pertussis, p. 309-325. In A. C. Wardlaw and R. Parton (ed.), Pathogenesis and immunity in pertussis. John Wiley & Sons, Chichester, England.
48. Sato, H., Y. Sato, and I. Ohishi, 1991. Comparison of pertussis toxin (PT)- neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies. Infect. Immun. 59:3832-3835.
49. Saukkonen, K., C. Cabenos, M. Burroughs, S. Prasad, and E. Tuomanen. 1991. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1143-1149.
50. Sehmitt, H, J., C. H. Wirsingyon König, A. Neiss, H. Bogaerts, H. L. Buck, H. Schulte-Wissermann, M. Gahr, R. Schult, J. U. Folkens, W. Rauh, and R. Clemens. 1996. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275:37-41
51. + T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112:1161-1182.
52. Shahin, R. D., M. J. Brennan, Z. M. Li, B. D. Meade, and C. R. Manclark. 1990. Characterization of the protective capacity, and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis J. Exp. Med. 171:63-73.
53. Thomas, M. G., K. Redhead, and H. P. Lambert. 1989. Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination. J. Infect. Dis. 159:211-218.
54. Tomoda, T., H. Oguraand, and T. Kurashige. 1991. Immune responses to Bordetella pertussis infection and vaccination. J. Infect. Dis. 163:559-563.